comprehensive -WSS

comprehensive

author：fashion 2025-08-12 08:28:39 - browse：136

Under the Affordable Care Act, health insurers are required to cover all costs associated with preventive care — including PrEP, or pre-exposure prophylactic treatment for HIV. But now all preventive care coverage is under threat, thanks to a lawsuit filed by employers who believe they shouldn’t be required to pay for care that violates their religious beliefs.

While coverage for PrEP access is largely unchanged as the court case makes its way through the legal system, Richard Hughes IV, a partner with the law firm Epstein Becker Green, says that protecting the status quo isn’t enough. For instance, currently you have to jump through extra hoops to get long-acting injectable PrEP covered by insurance.

But Hughes has a better idea for how to not only protect but also expand access to PrEP.

On this episode of the “First Opinion Podcast,” I spoke to Hughes about his proposal, why access to PrEP has never been what it should be, the Supreme Court’s current approach to health care, and more.

“If a provider has a bad experience with a previous patient experiencing non-coverage, they might say to the next patient, ‘Well, I’m not sure this is going to be covered.’ And that can be really discouraging,” Hughes said. “What we really need to create that clarity for patients is for this law to be upheld, for the recommendations to be clear, and for providers to have the assurance that they will be covered by payers.”

Our conversation was based on his recent First Opinion op-ed, “How to protect PrEP coverage, no matter what happens in Braidwood v. Becerra.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — First Opinion authors to feature on the podcast, kudos, or darts — email us at [email protected] and please put “podcast” in the subject line.

Previous article： In Memoriam: Notable people who died in 2023
Next article： Use doctors trained outside the U.S. to ease the physician shortage

focus

leisure time

WSS

Cord blood banking comes at a high cost to babies

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

With trial win, GSK could get blood cancer drug back on market

Ultragenyx gene therapy for rare liver ailment succeeds in late

Vertex cell therapy lets patients with type 1 diabetes stop insulin

hotspot

comprehensive

focus

Alkermes shareholders re

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Trump demands the U.S. pay no more for drugs than other countries … again

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Psychedelics group wrestles with new pharma identity

STAT wants to know your pick for a great summer read or listen

State Dept. review finds Biden bears some blame for Afghanistan failures

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

knowledge

With trial win, GSK could get blood cancer drug back on market

The Pandemic Treaty must support building strong health systems

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Shifting the focus from loneliness to social health

Canadians with cystic fibrosis outlive Americans by a decade

hotspot

focus

leisure time

hotspot